1. Chapter 3: Management of progression and complications of CKD
Kidney International Supplements 
Volume 3, Issue 1, Pages (January 2013)
DOI: /kisup
Copyright © 2013 International Society of Nephrology Terms and Conditions

2. Figure 19
Summary estimates for risks of all-cause mortality and cardiovascular mortality associated with levels of serum phosphorus, PTH, and calcium. PTH, parathyroid hormone. Reprinted with permission from Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305(11): Copyright © (2011) American Medical Association. All rights reserved. Accessed
Kidney International Supplements 2013 3, 73-90DOI: ( /kisup )
Copyright © 2013 International Society of Nephrology Terms and Conditions

3. Figure 20
Prevalence of deficiency of 1,25(OH)2D3, 25(OH)D3, and secondary hyperparathyroidism by GFR intervals. GFR, glomerular filtration rate; PTH, parathyroid hormone. Adapted by permission from Macmillan Publishers Ltd: Kidney International. Levin A, Bakris GL, Molitch M, et al.367 Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38; accessed
Kidney International Supplements 2013 3, 73-90DOI: ( /kisup )
Copyright © 2013 International Society of Nephrology Terms and Conditions